Search filters

List of works by Andreas Wicki

AKT-ions with a TWIST between EMT and MET

scientific article

Acquired Resistance to Clinical Cancer Therapy: A Twist in Physiological Signaling

scientific article published on July 2016

Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10

scientific article published on 14 December 2018

Determination of the donor:host blood cell ratio after haematological stem cell transplant by means of semiquantitative detection of short tandem repeat polymorphisms

scientific article published on 01 June 2002

Diet and cancer

2011 scientific article in Swiss Medical Weekly

Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT.

scientific article published in July 2010

First-in human, phase 1, dose-escalation pharmacokinetic and pharmacodynamic study of the oral dual PI3K and mTORC1/2 inhibitor PQR309 in patients with advanced solid tumors (SAKK 67/13).

scientific article published on 13 April 2018

Grover's-like drug eruption in a patient with metastatic melanoma under ipilimumab therapy. ⬇️

scientific article published on 16 August 2016

Immunoliposomal delivery of doxorubicin can overcome multidrug resistance mechanisms in EGFR-overexpressing tumor cells.

scientific article

Inflammatory cytokines induce podoplanin expression at the tumor invasive front.

scientific article published on 16 February 2018

Inhibition of Akt and other AGC kinases: A target for clinical cancer therapy?

scientific article published on May 2017

Integrated Akt/PKB signaling in immunomodulation and its potential role in cancer immunotherapy

scientific article published on 11 June 2015

Kras in metastatic colorectal cancer

scientific article

Large-scale manufacturing of GMP-compliant anti-EGFR targeted nanocarriers: production of doxorubicin-loaded anti-EGFR-immunoliposomes for a first-in-man clinical trial

scientific article published on 18 February 2015

NCAM-induced focal adhesion assembly: a functional switch upon loss of E-cadherin

scientific article published on 4 September 2008

Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications

scientific article published on 26 December 2014

PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination Therapy.

scientific article

Pre-existing antihypertensive treatment predicts early increase in blood pressure during bevacizumab therapy: the prospective AVALUE cohort study

scientific article published on 08 April 2014

Reliability of liquid biopsy analysis: an inter-laboratory comparison of circulating tumor DNA extraction and sequencing with different platforms

scientific article published on 02 July 2020

SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized phase I

scientific article published on 10 October 2016

Simultaneous targeting of VEGF-receptors 2 and 3 with immunoliposomes enhances therapeutic efficacy

scientific article published on 23 July 2015

Single-Center Experience with a Targeted Next Generation Sequencing Assay for Assessment of Relevant Somatic Alterations in Solid Tumors.

scientific article

SwissMTB: establishing comprehensive molecular cancer diagnostics in Swiss clinics

article

Synergism of peptide receptor-targeted Auger electron radiation therapy with anti-angiogenic compounds in a mouse model of neuroendocrine tumors

scientific article published on 16 February 2014

Systemic inflammation in a melanoma patient treated with immune checkpoint inhibitors-an autopsy study

scientific article published on 15 March 2016

Targeting tumor-associated endothelial cells: anti-VEGFR2 immunoliposomes mediate tumor vessel disruption and inhibit tumor growth

scientific article

The potential role of podoplanin in tumour invasion

scientific article

Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study.

scientific article published on 13 November 2012

Towards More Structure: Comparing TNM Staging Completeness and Processing Time of Text-Based Reports versus Fully Segmented and Annotated PET/CT Data of Non-Small-Cell Lung Cancer

scientific article published on 01 November 2018

Trametinib after disease reactivation under dabrafenib in Erdheim-Chester disease with both BRAF and KRAS mutations

scientific article published on 9 December 2016

Vemurafenib-induced radiation recall dermatitis: case report and review of the literature

scientific article

[Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma

scientific article published in June 2007

[Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting.

scientific article published on December 2006

[Melanoma- finally good news].

scientific article published in May 2013

[Stivarga shows effectiveness in practice]

scientific article published in May 2014

Paulina is supported by:

About Paulina

Help